156 related articles for article (PubMed ID: 34321225)
1. Specific cell differentiation in breast cancer: a basis for histological classification.
Rakha E; Toss M; Quinn C
J Clin Pathol; 2022 Feb; 75(2):76-84. PubMed ID: 34321225
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations in metaplastic breast carcinoma.
Cooper CL; Karim RZ; Selinger C; Carmalt H; Lee CS; O'Toole SA
J Clin Pathol; 2013 Jun; 66(6):522-8. PubMed ID: 23372178
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
[TBL] [Abstract][Full Text] [Related]
4. [New prognostic and predictive markers for breast cancer].
Wachter DL
Pathologe; 2016 Nov; 37(Suppl 2):217-222. PubMed ID: 27638528
[TBL] [Abstract][Full Text] [Related]
5. Head to head: do neuroendocrine tumours in the breast truly exist?
Rakha E; Tan PH
Histopathology; 2022 Jul; 81(1):2-14. PubMed ID: 35133666
[TBL] [Abstract][Full Text] [Related]
6. [Neuroendocrine differentiation in breast cancer].
Kreipe HH
Pathologe; 2019 Dec; 40(Suppl 3):325-330. PubMed ID: 31781853
[TBL] [Abstract][Full Text] [Related]
7. Discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
Lopez-Bonet E; Menendez JA
Ann Oncol; 2010 Apr; 21(4):901-902. PubMed ID: 20032125
[No Abstract] [Full Text] [Related]
8. Classification and grading of invasive breast carcinoma.
Elston CW
Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
[TBL] [Abstract][Full Text] [Related]
9. Tumour biology and histopathology of neuroendocrine tumours.
Klöppel G
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
McCart Reed AE; Kalaw E; Nones K; Bettington M; Lim M; Bennett J; Johnstone K; Kutasovic JR; Saunus JM; Kazakoff S; Xu Q; Wood S; Holmes O; Leonard C; Reid LE; Black D; Niland C; Ferguson K; Gresshoff I; Raghavendra A; Harvey K; Cooper C; Liu C; Kalinowski L; Reid AS; Davidson M; Pearson JV; Pathmanathan N; Tse G; Papadimos D; Pathmanathan R; Harris G; Yamaguchi R; Tan PH; Fox SB; O'Toole SA; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2019 Feb; 247(2):214-227. PubMed ID: 30350370
[TBL] [Abstract][Full Text] [Related]
11. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
12. Low-grade fibromatosis-like spindle cell carcinomas of the breast are molecularly exiguous.
Takano EA; Hunter SM; Campbell IG; Fox SB
J Clin Pathol; 2015 May; 68(5):362-7. PubMed ID: 25713418
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of cell line models for triple-negative breast cancers.
Grigoriadis A; Mackay A; Noel E; Wu PJ; Natrajan R; Frankum J; Reis-Filho JS; Tutt A
BMC Genomics; 2012 Nov; 13():619. PubMed ID: 23151021
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
Bhargava R; Beriwal S; Striebel JM; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.
Kleist B; Poetsch M
World J Gastroenterol; 2015 Nov; 21(41):11740-7. PubMed ID: 26556999
[TBL] [Abstract][Full Text] [Related]
16. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptors and breast cancer.
van Eijck CH; Kwekkeboom DJ; Krenning EP
Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?
van Deurzen CH; Lee AH; Gill MS; Menke-Pluijmers MB; Jager A; Ellis IO; Rakha EA
J Pathol; 2011 Aug; 224(4):434-7. PubMed ID: 21462188
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
20. Hormones and progeny of breast tumor cells.
Schneider HP; Böcker W
Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
